Aims The purpose of this study was to determine the feasibility of a new positron emission
tomography (PET) imaging approach using an 18F-labelled αvβ3 integrin antagonist (18F …

18F-galacto-RGD (18F-RGD) is a PET tracer binding to αvβ3 integrin receptors that are
upregulated after myocardial infarction (MI) as part of the healing process. We studied …

Background Radiolabeled RGD peptides detect α v β 3 integrin expression associated with
angiogenesis and extracellular matrix remodeling after myocardial infarction. We studied …

Purpose The α v β 3 integrin represents a potential target for noninvasive imaging of
angiogenesis. The purpose of this study was to evaluate a novel one-step labeled integrin α …

A 35-year-old Caucasian male presented with chest pain and nausea in the emergency
room. The initial ECG displayed sinus-rhythm with ST elevation in I, aVL, V1–5, ST …

Purpose Increased angiogenesis after myocardial infarction is considered an important
favorable prognostic parameter. The αvβ3 integrin is a key mediator of cell-cell and cell …

Background Inflammation and angiogenesis play an important role in atherosclerotic plaque
rupture. Therefore, molecular imaging of these processes could be used for determination of …

Purpose We evaluated a dimeric RGD-peptide,[68 Ga] DOTA-E-[c (RGDfK)] 2, for positron
emission tomography (PET) imaging of myocardial integrin expression associated with …

Background Expression of α v β 3 integrin is increased after myocardial infarction as part of
the repair process. Increased expression of α v β 3 has been shown by molecular imaging …

Purpose The α v β 3 integrin is expressed in angiogenic vessels and is a potential target for
molecular imaging of evolving pathological processes. Its expression is upregulated in …